To verify whether CARHSP1 could promoting the prostate cancer metastasis in vivo, the 22RV1 sublines (22Rv1/shCon and 22Rv1/shCAR groups) were used to establish the tail-vein injection metastasis mouse models. This evidence concerns the gene CARHSP1 and prostate carcinoma.